Status:
UNKNOWN
Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes
Lead Sponsor:
feng Zheng
Conditions:
Gastric Cancer
Type 2 Diabetes
Eligibility:
All Genders
30-70 years
Phase:
PHASE2
PHASE3
Brief Summary
Gastric bypass improves glycemic levels in type 2 diabetes. However, the efficacy may be varied by different gastric-small intestine reconstruction used in the procedure. There are reports that Roux e...
Detailed Description
Type 2 diabetes may cause severe complications such as nephropathy and retinopathy. Additionally, it is associated with increased risk for cardiovascular events and diseases. Surgical intervention wit...
Eligibility Criteria
Inclusion
- Diagnosed with Type 2 diabetes
- Diagnosed with gastric cancer
Exclusion
- Type 1 diabetes
- Unresectable cancers
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01528059
Start Date
February 1 2012
End Date
March 1 2013
Last Update
February 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DongFang Hospital
Fuzhou, Fujian, China, 350025